{2-[2-(1H-1,3-Benzimidazol-2-yl)ethyl­imino­meth­yl]-4-bromo­phenolato}thio­cyanato­copper(II) methanol solvate

In the title compound, [Cu(NCS)(C₁₆H₁₃BrN₃O)]·CH₄O, the Cu^II center forms a distorted square coordination with two N atoms and one O atom of the ligand 2-{2-[(5-bromo­salicyl­idene)amino]eth­yl}-1H-1,3-benzimidazole, and one N atom of the thio­cyanate anion. The distortion is quite large, with an O-Cu-N angle of 150.83 (10)° and an N-Cu-N angle of 149.17 (12)°. Methanol mol­ecules link the salicyl­idene groups via hydrogen bonds.

{2-[2-(1H-Benzimidazol-2-yl)ethyl­imino­meth­yl]-4-bromo­phenolato}chloro­zinc(II) methanol solvate

The title compound, [Zn(C₁₆H₁₃BrN₃)Cl]·CH₄O, has been prepared by the reaction of 2-[2-(1H-benzimidazol-2-yl)ethyl­imino­meth­yl]-4-bromo­phenol with zinc(II) chloride. The central Zn atom is coordinated by two N atoms and one O atom from the phenolate ligand, along with a Cl⁻ anion, which provide a distorted tetra­hedral enviroment. Inter­molecular O—H...O and N—H...O hydrogen bonds link two Zn complex mol­ecules and two methanol solvent mol­ecules into a centrosymmetric cluster. The crystal packing is further stabilized by weak C—H...Cl hydrogen bonds.